17,520 resources
By Version
By Realm
Start Prev Rows 8200 - 8400 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Source(s) |
---|---|---|---|---|---|---|---|---|---|
fhir.cdc.opioid-cds-r4 | R4 | buprenorphine-medications | Buprenorphine Medications | active | 2025-02 | us | |||
hl7.terminology | R5 | cpt-usable | AMA CPT Usable Codes | active | vocab | 2023-08 | uv | cpt | |
fhir.dicom | R4 | all | All DICOM Controlled Terminology Definitions | active | 2025-04 | us | dcm | ||
hl7.v2plus | R5 | data-types | v2DataTypes | trial-use | inm | 2025-07 | |||
hl7.fhir.us.icsr-ae-reporting | R4 | ISBTConvalescentPlasmaCodeVS | ISBT Convalescent Plasma Codes | draft | 2023-08 | us | |||
hl7.fhir.us.icsr-ae-reporting | R4 | ISBTBloodProductCodeVS | ISBT Blood Product Codes | draft | 2023-08 | us | |||
hl7.fhir.us.registry-protocols | R4 | SEattleAnginaQs | Seattle Angina Questions | active | cic | 2023-11 | us | loinc | |
fhir.tx.support.r4 | R4 | covid-19-obs | COVID-19 related Observation codes | draft | 2020-03 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1267.13 | Screening and Assessment Survey Codes | active | 2024-10 | us | loinc | ||
hl7.org.nz.fhir.ig.formulary | R4B | NzmtCodes | NZMT Codes | active | 2025-07 | nz | |||
fhir.cdc.opioid-cds-r4 | R4 | oxycodone-medications | Oxycodone Medications | active | 2025-02 | us | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.58 | Diabetes Medications | active | 2022-03 | us | rx | ||
fhir.tx.support.r4 | R4 | covid-19-cond | COVID-19 related Condition codes | draft | 2020-03 | us | sct | ||
hl7.fhir.us.registry-protocols | R4 | HemodialysisOrPeritonealDialysis | hemodialysis or peritoneal dialysis | active | cic | 2023-11 | us | sct | |
hl7.fhir.us.registry-protocols | R4 | CardiacArrest | Cardiac Arrest | active | cic | 2023-11 | us | sct | |
hl7.fhir.us.registry-protocols | R4 | CABG | Coronary artery bypass grafting | active | cic | 2023-11 | us | sct | |
hl7.fhir.us.registry-protocols | R4 | CerebrovascularDisease | Cerebrovascular Disease | active | cic | 2023-11 | us | sct | |
hl7.fhir.us.registry-protocols | R4 | PeripheralArterialOcclusiveDisease | Peripheral Arterial Occlusive Disease | active | cic | 2023-11 | us | sct | |
hl7.fhir.us.registry-protocols | R4 | DiabetesMellitus | Diabetes Mellitus | active | cic | 2023-11 | us | sct | |
hl7.fhir.us.registry-protocols | R4 | Dyslipidemia | Dyslipidemia | active | cic | 2023-11 | us | sct | |
hl7.fhir.us.registry-protocols | R4 | HeartFailure | Heart Failure codes from SNOMED | active | cic | 2023-11 | us | sct | |
hl7.fhir.us.registry-protocols | R4 | Hypertension | Hypertension | active | cic | 2023-11 | us | sct | |
hl7.fhir.us.registry-protocols | R4 | PercutaneousCoronaryIntervention | PCI | active | cic | 2023-11 | us | sct | |
hl7.fhir.us.registry-protocols | R4 | PriorCABG | Prior History of Coronary Artery Bypass Graft | active | cic | 2023-11 | us | sct loinc | |
hl7.fhir.us.registry-protocols | R4 | HypothermiaInduced | Induced Hypothermia Codes | active | cic | 2023-11 | us | sct | |
hl7.fhir.us.registry-protocols | R4 | OrganDonor | SNOMED Valueset of Organ Donor codes | active | cic | 2023-11 | us | sct | |
hl7.fhir.us.registry-protocols | R4 | AbnormalElectrocardiacAssessment | Abnormal Electrocardiac Assessment | active | cic | 2023-11 | us | sct | |
fhir.cdc.opioid-cds-r4 | R4 | benzodiazepine-medications | Benzodiazepine medications | active | 2025-02 | us | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.230 | All Cancer Directed therapies | active | 2024-05 | us | rx | ||
hl7.terminology | R5 | v3-IndividualCaseSafetyReportType | IndividualCaseSafetyReportType | active | 2014-03 | uv | tho | ||
de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | cochrane-pico | Cochrane PICO | draft | 2022-09 | uv | |||
hl7.fhir.uv.saner | R4 | MeasureScoring | Measure Scoring | active | pher | 2024-05 | uv | fhir | |
hl7.terminology | R5 | cpt-all | AMA CPT All Codes | active | vocab | 2023-08 | uv | cpt | |
hl7.terminology | R5 | cpt-base | AMA CPT Base Codes | active | vocab | 2023-08 | uv | cpt | |
hl7.fhir.us.registry-protocols | R4 | FamilyPrematureCAD | Family History of Premature CAD | active | cic | 2023-11 | us | sct loinc | |
hl7.fhir.uv.cqm | R4 | iso-8601-derived-periods | ISO-8601-Derived Periods | active | cqi | 2025-06 | uv | tho | |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.158 | Multiple Myeloma Regimen Drugs | active | 2019-08 | us | rx | ||
ee.hl7.fhir.base.r5 | R5 | ee-identity-system | Identity System | draft | 2023-08 | ee | internal | ||
ee.fhir.terminology | R5 | identifier-domain | Identity System | active | 2025-06 | ee | internal | ||
de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | cochrane-pico-intervention | Cochrane PICO Intervention | draft | 2022-09 | uv | |||
hl7.eu.fhir.unicom | R5 | language-bcp-vs | Language (FHIR) | draft | 2025-06 | eu | fhir | ||
fhir.cdc.opioid-cds-r4 | R4 | naloxone-medications | Naloxone medications | active | 2025-02 | us | |||
fhir.cdc.opioid-cds-r4 | R4 | cdc-malignant-cancer-conditions | CDC malignant cancer conditions | active | 2023-05 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.226 | Opioids, All | active | 2024-01 | us | rx | ||
fhir.cdc.opioid-cds-r4 | R4 | opioid-analgesics-with-ambulatory-misuse-potential | Opioid analgesics with ambulatory misuse potential | active | 2025-02 | us | |||
fhir.cdc.opioid-cds-r4 | R4 | extended-release-opioid-with-ambulatory-misuse-potential | Extended release opioid with ambulatory misuse potential | active | 2025-02 | us | |||
de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | cochrane-pico-outcome | Cochrane PICO Outcome | draft | 2022-09 | uv | |||
de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | cochrane-pico-population | Cochrane PICO Population | draft | 2022-09 | uv | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1053 | Carbidopa Levodopa Combination (RXNORM) | active | 2025-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.2362 | Tuberculosis (Ethambutol) (RXNORM) | active | 2024-06 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.2363 | Tuberculosis (Isoniazid [INH]) (RXNORM) | active | 2024-06 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.2364 | Tuberculosis (Pyrazinamide [PZA]) (RXNORM) | active | 2024-06 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.2365 | Tuberculosis (Rifabutin) (RXNORM) | active | 2024-06 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.2366 | Tuberculosis (Rifampin) (RXNORM) | active | 2024-06 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.2367 | Tuberculosis (Rifapentine) (RXNORM) | active | 2024-06 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.741 | Hepatitis B Immune Globulin (RXNORM) | active | 2023-06 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.747 | Penicillin G [Benzathine] [Injectable] [Bicillin] (RXNORM) | active | 2025-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.844 | Tuberculosis (Second Line Drugs for Treatment) (RXNORM) | active | 2024-06 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.991 | Rifampin (RXNORM) | active | 2024-06 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1594 | HIV Infection (ARV Nucleoside Reverse Transcriptase Inhibitors [NRTIs]) (RXNORM) | active | 2023-06 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1595 | HIV Infection (ARV Non nucleoside Reverse Transcriptase Inhibitors [NNRTIs]) (RXNORM) | active | 2023-06 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1597 | HIV Infection (ARV Combination Treatment for HIV) (RXNORM) | active | 2023-06 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1598 | HIV Infection (ARV Protease Inhibitors [PIs]) (RXNORM) | active | 2023-06 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1600 | HIV Infection (ARV Integrase Strand Transfer Inhibitors [INSTIs]) (RXNORM) | active | 2023-06 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1634 | Sofosbuvir Velpatasvir Combination (RXNORM) | active | 2023-06 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1912 | Penicillin G [Aqueous Crystalline] [Injectable] (RXNORM) | active | 2023-01 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1913 | Penicillin G [Procaine] [Injectable] (RXNORM) | active | 2025-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1078 | Opioid Overdose and Poisoning (Naloxone) (RxNorm) | active | 2025-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1618 | Smallpox Vaccine (RXNORM) | active | 2023-06 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.2142 | Linezolid (RXNORM) | active | 2023-01 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.2143 | Tuberculosis (Pretomanid) (RXNORM) | active | 2023-01 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.2144 | Tuberculosis (Bedaquiline) (RXNORM) | active | 2023-01 | us | rx | ||
hl7.terminology | R5 | v3-EntityClassMicroorganism | EntityClassMicroorganism | active | 2014-03 | uv | tho | ||
hl7.fhir.uv.extensions | R5 | questionnaire-derivationType | Questionnaire Derivation Type Valueset | draft | fhir | 2025-07 | uv | fhir | |
de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | vs-substances-snomed | Substances SNOMED CT | draft | 2022-09 | uv | sct | ||
de.basisprofil.r4 | R4 | UcumVitalsCommonDE | UCUM Vitals Common DE | active | 2025-06 | ucum | |||
de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | vs-allergic-disposition-sct | Allergic Disposition SCT | draft | 2022-09 | uv | sct | ||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.2--20200901000000 | AllergieCategorieCodelijst | active | nl | sct tho | |||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.3--20200901000000 | AllergieStatusCodelijst | active | nl | tho | |||
hl7.fhir.be.allergy | R4 | be-allergyintolerancecode | BeAllergyIntoleranceCode | active | 2025-07 | be | internal | ||
hl7.fhir.eu.hdr | R4 | allergy-intolerance-eu-hdr | Allergy Intolerance (with exceptions) | draft | 1 | 2025-06 | eu | internal fhir | |
hl7.fhir.eu.hdr | R4 | allergy-intolerance-substances-eu-hdr | Allergy Intolerance | draft | 1 | 2025-06 | eu | sct | |
hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.2--20161206000000 | Allergy or Intolerance Type | draft | 2024-08 | uv | tho oid | ||
hl7.fhir.uv.saner | R4 | MeasureStatus | Measure Status Values | active | pher | 2024-05 | uv | fhir | |
hl7.fhir.us.davinci-crd | R4 | configTypes | CRD Configuration Code Data Types Value Set | trial-use | 4 | fm | 2025-07 | us | fhir |
hl7.fhir.us.mcode | R4 | mcode-brachytherapy-high-dose-rate-technique-vs | Brachytherapy High Dose Rate Technique Value Set | active | 3 | cic | 2025-02 | us | sct |
hl7.fhir.us.mcode | R4 | mcode-brachytherapy-high-dose-rate-electronic-technique-vs | Brachytherapy High Dose Rate Electronic Technique Value Set | active | 3 | cic | 2025-02 | us | sct |
hl7.fhir.us.mcode | R4 | mcode-brachytherapy-low-dose-rate-temporary-technique-vs | Brachytherapy Low Dose Rate Temporary Radiation Technique Value Set | active | 3 | cic | 2025-02 | us | sct |
hl7.fhir.us.mcode | R4 | mcode-brachytherapy-pulsed-dose-rate-technique-vs | Brachytherapy Pulsed Dose Rate Technique Value Set | active | 3 | cic | 2025-02 | us | sct |
hl7.fhir.us.mcode | R4 | mcode-brachytherapy-permanent-seeds-technique-vs | Brachytherapy Permanent Seeds Technique Value Set | active | 3 | cic | 2025-02 | us | sct |
hl7.fhir.us.mcode | R4 | mcode-brachytherapy-radiopharmaceutical-technique-vs | Brachytherapy Radiopharmaceutical Technique Value Set | active | 3 | cic | 2025-02 | us | sct |
hl7.fhir.us.mcode | R4 | mcode-teleradiotherapy-carbon-ion-beam-technique-vs | Carbon Ion Beam Technique Value Set | active | 3 | cic | 2025-02 | us | sct |
hl7.fhir.us.mcode | R4 | mcode-teleradiotherapy-electron-beam-technique-vs | Electron Beam Technique Value Set | active | 3 | cic | 2025-02 | us | sct |
hl7.fhir.us.mcode | R4 | mcode-teleradiotherapy-neutron-beam-technique-vs | Neutron Beam Technique Value Set | active | 3 | cic | 2025-02 | us | sct |
hl7.fhir.us.mcode | R4 | mcode-teleradiotherapy-photon-beam-technique-vs | Photon Beam Technique Value Set | active | 3 | cic | 2025-02 | us | sct |
hl7.fhir.us.mcode | R4 | mcode-teleradiotherapy-proton-beam-technique-vs | Proton Beam Technique Value Set | active | 3 | cic | 2025-02 | us | sct |
hl7.fhir.uv.livd | R4 | livd-bundle-type | Allowed types of bundles for the LIVD catalog | draft | oo | 2019-07 | uv | fhir | |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.16 | Reasons for Interventions Related to Medication Management | active | 2022-03 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.558 | Butalbital analgesics | active | 2023-08 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.789 | Social Determinants of Health Procedures | active | 2024-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.790 | Social Determinants of Health Service Requests | active | 2024-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.11 | Food Insecurity Service Requests | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.118 | Health Literacy Procedures | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.119 | Health Literacy Service Requests | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.122 | Medical Cost Burden Procedures | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.123 | Medical Cost Burden Service Requests | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.124 | Health Insurance Coverage Status Service Requests | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.125 | Health Insurance Coverage Status Procedures | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.20 | Homelessness Procedures | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.21 | Homelessness Service Requests | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.226 | Digital Literacy Procedures | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.227 | Digital Literacy Service Requests | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.235 | Digital Access Procedures | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.236 | Digital Access Service Requests | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.247 | Utility Insecurity Procedures | active | 2024-05 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.252 | Utility Insecurity Service Requests | active | 2024-05 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.260 | Incarceration Status Procedures | active | 2024-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.261 | Incarceration Status Service Requests | active | 2024-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.268 | Language Access Procedures | active | 2024-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.269 | Language Access Service Requests | active | 2024-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.27 | Transportation Insecurity Procedures | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.28 | Transportation Insecurity Service Requests | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.31 | Financial Insecurity Service Requests | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.32 | Financial Insecurity Procedures | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.38 | Material Hardship Service Requests | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.39 | Material Hardship Procedures | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.44 | Housing Instability Procedures | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.45 | Housing Instability Service Requests | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.52 | Inadequate Housing Procedures | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.53 | Inadequate Housing Service Requests | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.56 | Less Than High School Education Procedures | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.57 | Less Than High School Education Service Requests | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.59 | Unemployment Procedures | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.60 | Unemployment Service Requests | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.67 | Elder Abuse Procedures | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.68 | Elder Abuse Service Requests | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.7 | Food Insecurity Procedures | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.87 | Stress Procedures | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.90 | Veteran Status Procedures | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.91 | Veteran Status Service Requests | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.92 | Stress Service Requests | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.94 | Social Connection Procedures | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.95 | Social Connection Service Requests | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.97 | Intimate Partner Violence Procedures | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.98 | Intimate Partner Violence Service Requests | active | 2024-06 | us | vsac | ||
hl7.fhir.be.patient-monitoring | R4 | holter-report-code | Holter Report Code | draft | 2025-07 | be | loinc | ||
hl7.terminology | R5 | v3-AmnioticFluidSacRoute | AmnioticFluidSacRoute | active | 2014-03 | uv | tho | ||
fhir.cdc.opioid-cds-r4 | R4 | amphetamines-class-medications | Amphetamine class medications | active | 2025-02 | us | |||
hl7.terminology | R5 | v3-ActClassCareProvision | ActClassCareProvision | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActStatusSuspended | ActStatusSuspended | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActStatusCompleted | ActStatusCompleted | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActStatusNew | ActStatusNew | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActStatusHeld | ActStatusHeld | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActClassContainerRegistration | ActClassContainerRegistration | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActClassProcedure | ActClassProcedure | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-RoleClassOwnedEntity | RoleClassOwnedEntity | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-RoleClassHealthcareProvider | RoleClassHealthcareProvider | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-RoleClassCommissioningParty | RoleClassCommissioningParty | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | hl7-work-group | HL7Workgroup | active | fhir | 2024-04 | uv | tho | |
hl7.terminology | R5 | v3-ActClassOutbreak2 | ActClassOutbreak2 | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-xRoleClassCoverageInvoice | x_RoleClassCoverageInvoice | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-xRoleClassCoverage | x_RoleClassCoverage | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActClassAccommodation | ActClassAccommodation | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActAccountCode | ActAccountCode | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActRelationshipSequel | ActRelationshipSequel | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActClassControlAct | ActClassControlAct | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActRelationshipSummarizedBy | ActRelationshipSummarizedBy | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActClassVerification | ActClassVerification | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActClassDisciplinaryAction | ActClassDisciplinaryAction | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-RoleLinkRelated | RoleLinkRelated | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-HospitalPracticeSetting | HospitalPracticeSetting | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActRelationshipIsAppendage | ActRelationshipIsAppendage | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ParticipationConsultant | ParticipationConsultant | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-EntityClassPublicInstitution | EntityClassPublicInstitution | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-RoleClassAssignedEntity | RoleClassAssignedEntity | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActClassContract | ActClassContract | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-HumanActSite | HumanActSite | retired | 2014-03 | uv | tho | ||
hl7.fhir.us.covid19library | R4 | covid-19-severity-value-set | COVID-19 Signs and Symptoms Severity Value Set | active | 2022-07 | us | sct | ||
hl7.terminology | R5 | v3-ActRelationshipIsManifestationOf | ActRelationshipIsManifestationOf | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActRelationshipIsEtiologyFor | ActRelationshipIsEtiologyFor | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-RoleClassPart | RoleClassPart | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-RoleClassPartitive | RoleClassPartitive | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-RoleClassPassive | RoleClassPassive | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-AmbulanceHIPAA | AmbulanceHIPAA | retired | 2014-03 | uv | nucc | ||
hl7.terminology | R5 | v3-ParticipationCustodian | ParticipationCustodian | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-RoleClassAgent | RoleClassAgent | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-RoleClassQualifiedEntity | RoleClassQualifiedEntity | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-RoleClassMaintainedEntity | RoleClassMaintainedEntity | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ParticipationInformationTranscriber | ParticipationInformationTranscriber | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-RoleClassInvestigationSubject | RoleClassInvestigationSubject | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-RoleClassSubsumer | RoleClassSubsumer | active | 2012-03 | uv | tho | ||
hl7.terminology | R5 | v3-RoleClassEmergencyContact | RoleClassEmergencyContact | active | 2014-03 | uv | tho | ||
hl7.fhir.us.breastcancer | R3 | oncology-TumorMarginDescriptionVS | BC TumorMarginDescriptionVS ValueSet | draft | 2018-08 | us | sct | ||
hl7.fhir.us.breastcancer | R3 | oncology-Ki-67NuclearAntigenVS | BC Ki-67NuclearAntigenVS ValueSet | draft | 2018-08 | us | sct | ||
hl7.terminology | R5 | v3-ActClassIncident | ActClassIncident | active | 2014-03 | uv | tho | ||
hl7.fhir.uv.extensions | R5 | practitionerrole-employmentStatus | Practitioner Role Employment Status value set | draft | pa | 2025-07 | uv | tho | |
hl7.fhir.uv.sdc | R4 | sdc-question-library-states | Australian States - example value set | active | fhir | 2025-07 | uv | fhir | |
signal.core.r4 | R4 | servicerequest-orderdetail | Service Request Order Details Codes | draft | 1 | oo | 2019-10 | us | sct |
hl7.fhir.uv.vulcan-rwd | R4 | ExampleAntiTNFADrugCodes | AntiTNFA Example Drug Codes | active | 2023-05 | uv | example | ||
hl7.fhir.uv.vulcan-rwd | R4 | ExampleACSConditionCodes | ACS Example Condition Codes | active | 2023-05 | uv | icd |